{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:19:15Z","timestamp":1784420355770,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Science and Technology Department","doi-asserted-by":"publisher","award":["QKHLH2016-7158"],"award-info":[{"award-number":["QKHLH2016-7158"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010891","name":"Department of Health of Guizhou Province","doi-asserted-by":"publisher","award":["gzwjkj2018-1-015"],"award-info":[{"award-number":["gzwjkj2018-1-015"]}],"id":[{"id":"10.13039\/501100010891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serum parathyroid hormone (PTH) levels have been reported to be associated with infectious mortality in peritoneal dialysis (PD) patients. Peritonitis is the most common and fatal infectious complication, resulting in technique failure, hospital admission and mortality. Whether PTH is associated with peritonitis episodes remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined the association of PTH levels and peritonitis incidence in a 7-year cohort of 270 incident PD patients who were maintained on dialysis between January 2012 and December 2018 using Cox proportional hazard regression analyses. Patients were categorized into three groups by serum PTH levels as follows: low-PTH group, PTH\u2009&lt;\u2009150\u2009pg\/mL; middle-PTH group, PTH 150-300\u2009pg\/mL; high-PTH group, PTH\u2009&gt;\u2009300\u2009pg\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 29.5 (interquartile range 16\u201349) months, the incidence rate of peritonitis was 0.10 episodes per patient-year. Gram-positive organisms were the most common causative microorganisms (36.2%), and higher percentage of Gram-negative organisms was noted in patients with low PTH levels. Low PTH levels were associated with older age, higher eGFR, higher hemoglobin, calcium levels and lower phosphate, alkaline phosphatase levels. After multivariate adjustment, lower PTH levels were identified as an independent risk factor for peritonitis episodes [hazard ratio 1.643, 95% confidence interval 1.014\u20132.663,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.044].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low PTH levels are independently associated with peritonitis in incident PD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02241-0","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:25:18Z","timestamp":1611908718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-455X","authenticated-orcid":false,"given":"Yan","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"2241_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, et al. The chronic kidney disease-mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone. 2017;100:80\u20136.","journal-title":"Bone."},{"key":"2241_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40620-017-0404-z","volume":"30","author":"J Bover","year":"2017","unstructured":"Bover J, Bailone L, Lopez-Baez V, et al. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. J Nephrol. 2017;30:677\u201387.","journal-title":"J Nephrol"},{"key":"2241_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40620-017-0398-6","volume":"30","author":"PAU Torres","year":"2017","unstructured":"Torres PAU, Cohen-Solal M. Evaluation of fracture risk in chronic kidney disease. J Nephrol. 2017;30:653\u201361.","journal-title":"J Nephrol."},{"key":"2241_CR4","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K, Shah A, Duong U, et al. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010;117:S10\u201321.","DOI":"10.1038\/ki.2010.189"},{"key":"2241_CR5","doi-asserted-by":"crossref","unstructured":"Toraman A, Aras F, Hekimsoy Z, et al. Is there a relationship between parathyroid hormone and neutrophil lymphocyte ratio or platelet lymphocyte ratio? Acta Endocrinol(Buchar). 2019;5:96\u2013101.","DOI":"10.4183\/aeb.2019.96"},{"key":"2241_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00041552-200007000-00007","volume":"9","author":"M Fukagawa","year":"2000","unstructured":"Fukagawa M, Akizawa T, Kurokawa K. Is aplastic osteodystrophy a disease of malnutrition? Curr Opin Nephrol Hypertens. 2000;9:363\u20137.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2241_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1020146023812","volume":"19","author":"E Carlstedt","year":"1999","unstructured":"Carlstedt E, Ridefelt P, Lind L, et al. Interleukin-6 induced suppression of bovine parathyroid hormone secretion. Biosci Rep. 1999;19:35\u201342.","journal-title":"Biosci Rep"},{"key":"2241_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.jrn.2009.10.006","volume":"20","author":"R Dukkipati","year":"2010","unstructured":"Dukkipati R, Kovesdy CP, Colman S, et al. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr. 2010;20:243\u201354.","journal-title":"J Ren Nutr"},{"key":"2241_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3904\/kjim.2018.264","volume":"35","author":"YA Hong","year":"2020","unstructured":"Hong YA, Kim JH, Kim YK, et al. Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study. Korean J Intern Med. 2020;35:160\u201370.","journal-title":"Korean J Intern Med"},{"key":"2241_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","volume":"64","author":"Y Cho","year":"2014","unstructured":"Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64:278\u201389.","journal-title":"Am J Kidney Dis"},{"key":"2241_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ckj\/sfx092","volume":"11","author":"C Crepaldi","year":"2018","unstructured":"Crepaldi C, Possidoni A, Caputo F, et al. Clinical management of patients on peritoneal dialysis in Italy: results from the ATENA study. Clin Kidney J. 2018;11:275\u201382.","journal-title":"Clin Kidney J"},{"key":"2241_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","volume":"36","author":"PK Li","year":"2016","unstructured":"Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36:481\u2013508.","journal-title":"Perit Dial Int"},{"key":"2241_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1053\/j.ajkd.2008.06.032","volume":"53","author":"DW Johnson","year":"2009","unstructured":"Johnson DW, Dent H, Hawley CM, et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis. 2009;53:290\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2241_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107485","volume":"9","author":"X Fan","year":"2014","unstructured":"Fan X, Huang R, Wang J, et al. Risk factors for the first episode of peritonitis in southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One. 2014;9:e107485.","journal-title":"PLoS One"},{"issue":"49","key":"2241_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005569","volume":"95","author":"Y Tian","year":"2016","unstructured":"Tian Y, Xie X, Xiang S, et al. Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: a retrospective study. Medicine. 2016;95(49):e5569.","journal-title":"Medicine."},{"key":"2241_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"2241_CR17","doi-asserted-by":"crossref","unstructured":"Kidney disease: improving global outcomes CKDMBDUWG (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2011;7:1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"2241_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52:519\u201330.","journal-title":"Am J Kidney Dis"},{"key":"2241_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.ajkd.2010.08.037","volume":"57","author":"N Tangri","year":"2011","unstructured":"Tangri N, Wagner M, Griffith JL, et al. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom renal registry. Am J Kidney Dis. 2011;57:415\u201321.","journal-title":"Am J Kidney Dis"},{"key":"2241_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0272-6386(99)70012-0","volume":"34","author":"AJ Collins","year":"1999","unstructured":"Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065\u201374.","journal-title":"Am J Kidney Dis"},{"key":"2241_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-017-0588-4","volume":"18","author":"H Ye","year":"2017","unstructured":"Ye H, Zhou Q, Fan L, et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrol. 2017;18:186.","journal-title":"BMC Nephrol"},{"key":"2241_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/met.2012.0056","volume":"10","author":"R Alemzadeh","year":"2012","unstructured":"Alemzadeh R, Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord. 2012;10:422\u20139.","journal-title":"Metab Syndr Relat Disord"},{"key":"2241_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ki.1993.255","volume":"44","author":"E Lewin","year":"1993","unstructured":"Lewin E, Ladefoged J, Brandi L, et al. Parathyroid hormone dependent T cell proliferation in uremic rats. Kidney Int. 1993;44:379\u201384.","journal-title":"Kidney Int"},{"key":"2241_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1006\/bbrc.1997.7207","volume":"238","author":"PK Nielsen","year":"1997","unstructured":"Nielsen PK, Rasmussen AK, Butters R, et al. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Commun. 1997;238:880\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2241_CR25","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0041-1345(02)02846-4","volume":"34","author":"FN Ozdemir","year":"2002","unstructured":"Ozdemir FN, Yakupoglu U, Turan M, et al. Role of parathormone levels on T-cell response in hemodialysis patients. Transplant Proc. 2002;34:2044\u20135.","journal-title":"Transplant Proc"},{"key":"2241_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000368940","volume":"39","author":"OM Akchurin","year":"2015","unstructured":"Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84\u201392.","journal-title":"Blood Purif"},{"key":"2241_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/sdi.12010","volume":"26","author":"RF Singer","year":"2013","unstructured":"Singer RF. Vitamin D in dialysis: defining deficiency and rationale for supplementation. Semin Dial. 2013;26:40\u20136.","journal-title":"Semin Dial"},{"key":"2241_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3747\/pdi.2014.00177","volume":"35","author":"HC Pi","year":"2015","unstructured":"Pi HC, Ren YP, Wang Q, et al. Serum 25-hydroxyvitamin D level could predict the risk for peritoneal dialysis-associated peritonitis. Perit Dial Int. 2015;35:729\u201335.","journal-title":"Perit Dial Int"},{"key":"2241_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067836","volume":"8","author":"J Kerschbaum","year":"2013","unstructured":"Kerschbaum J, Vychytil A, Lhotta K, et al. Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritoneal dialysis. PLoS One. 2013;8:e67836.","journal-title":"PLoS One"},{"key":"2241_CR30","doi-asserted-by":"crossref","unstructured":"Guhn JY, Chen HC, Chuang HY, et al. Risk factors and risk for mortality of mild hypothyroidism in hemodialysis patients. Am J Kidney Dis. 2002:1245\u201354.","DOI":"10.1053\/ajkd.2002.33398"},{"key":"2241_CR31","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","volume":"32","author":"P Evenepoel","year":"2017","unstructured":"Evenepoel P, Poesen R, Meijers B. The gut\u2013kidney axis. Pediatr Nephrol. 2017;32:2005\u201314.","journal-title":"Pediatr Nephrol"},{"key":"2241_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5414\/CN107249","volume":"77","author":"CY Su","year":"2012","unstructured":"Su CY, Pei J, Lu XH, et al. Gastrointestinal symptoms predict peritonitis rates in CAPD patients. Clin Nephrol. 2012;77:267\u201374.","journal-title":"Clin Nephrol"},{"key":"2241_CR33","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.nut.2019.110713","volume":"73","author":"S Mirzaeian","year":"2020","unstructured":"Mirzaeian S, Saraf-Bank S, Entezari MH, et al. Effect of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in hemodialysis patients: a double-blind placebo-controlled randomized clinical trial. Nutrition. 2020;73:110713.","journal-title":"Nutrition."},{"key":"2241_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000494145","volume":"48","author":"G Kosmadakis","year":"2018","unstructured":"Kosmadakis G, Albaret J, Corrreia EC, et al. Gastrointestinal disorders in peritoneal Dialysis patients. Am J Nephrol. 2018;48:319\u201325.","journal-title":"Am J Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-021-02241-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:27:49Z","timestamp":1611908869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02241-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-55536\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-55536\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-55536\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-55536\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the Declaration of Helsinki and was approved by Guizhou Provincial People\u2019s Hospital\u2019s institutional committee (ID:2018068). As the data were obtained retrospectively from patient charts, informed consent was deemed unnecessary following the above guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}